Monique Silvy
Research Subjects
Monique Silvy has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Jacques Chiaroni
Biologie des Groupes Sanguins, Établissement Français du Sang PACA Corse, Marseille, France
10 shared publicationsPascal Bailly
Biologie des Groupes Sanguins, Établissement Français du Sang PACA Corse, Marseille, France
9 shared publicationsSophie Beley
Laboratoire d'Hématologie Moléculaire: Biologie des Groupes Sanguins, Établissement Français du Sang Alpes Méditerranée, Marseille, France
4 shared publicationsLugdivine Filosa
Biologie des Groupes Sanguins, Établissement Français du Sang PACA Corse, Marseille, France
3 shared publicationsThomas Granier
Etablissement Français du Sang Alpes Méditerranée
3 shared publicationsAlhassane Ba
Centre National de Transfusion Sanguine (CNTS), BP E344, Bamako, Mali; Etablissement Français du Sang Alpes Méditerranée, Marseille, France; UMR 7268 ADÉS, Aix-Marseille Université - EFS - CNRS, Marseille, France
2 shared publications
Latest Publications
- 27 June 2019
- Published by Wiley in Transfusion
- Vol. 59 (8) , 2754-2755
Identification and characterization of three novel RHCE*ce variant alleles affecting Rhc (RH4) reactivity
- 27 June 2019
- Published by Wiley in Transfusion
- Vol. 59 (8) , 2754-2755
Identification and characterization of three novel RHCE*ce variant alleles affecting Rhc (RH4) reactivity
- 28 March 2019
- Published by Wiley in Transfusion
- Vol. 59 (6) , 2160-2161
The c.939G>A synonymous polymorphism inRHCEcan be encountered on different molecular backgrounds
- 28 March 2019
- Published by Wiley in Transfusion
- Vol. 59 (6) , 2160-2161
The c.939G>A synonymous polymorphism inRHCEcan be encountered on different molecular backgrounds
- 5 February 2017
- Published by Wiley in Transfusion
- Vol. 57 (5) , 1248-1253
First description of aD-CE-Dhybrid gene on aweak D Type 2molecular background
Altogether, we identified the first example of an RHD-CE-D large hybrid allele on a weak D Type 2 background associated with an RhD-negative phenotype. By investigating the RHCE-D breakpoint zones, we suggest a mobile element-mediated recombination.
- 5 February 2017
- Published by Wiley in Transfusion
- Vol. 57 (5) , 1248-1253
First description of aD-CE-Dhybrid gene on aweak D Type 2molecular background
Altogether, we identified the first example of an RHD-CE-D large hybrid allele on a weak D Type 2 background associated with an RhD-negative phenotype. By investigating the RHCE-D breakpoint zones, we suggest a mobile element-mediated recombination.
- 18 May 2016
- Published by Wiley in Transfusion
- Vol. 56 (8) , 2154-2155
New silent and weak D alleles: molecular characterization and associated antigen density
- 18 May 2016
- Published by Wiley in Transfusion
- Vol. 56 (8) , 2154-2155
New silent and weak D alleles: molecular characterization and associated antigen density
- 1 April 2016
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 54 (2) , 289-295
Genotyping of 28 blood group alleles in blood donors from Mali: Prediction of rare phenotypes
- 1 April 2016
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 54 (2) , 289-295
Genotyping of 28 blood group alleles in blood donors from Mali: Prediction of rare phenotypes
- 20 March 2016
- Published by Wiley in Transfusion
- Vol. 56 (5) , 1223-1229
New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes
BACKGROUND: The KELL antigens are carried by the well‐folded and highly polymorphic glycoprotein KELL, belonging to the M13 family of metalloproteases. Anti‐KEL, particularly anti‐KEL1, are clinically significant. We retrospectively investigated genomic DNA from samples with uncertain KEL1 or KEL2 phenotype and identified six novel Kmod alleles. We then considered a model of the protein three‐dimensional (3D) structure to assess the impacts of the amino acid changes.STUDY DESIGN AND METHODS: The 19 exons of the KEL gene were polymerase chain reaction amplified and sequenced. Modeling was performed using the experimental 3D structure of human endothelin‐converting enzyme‐1 in the presence of the metabolite phosphoramidon.RESULTS: We identified four novel KEL*01M alleles with amino acid substitutions p.Arg447Trp, p.Gly641Arg, p.Ala645Val, and p.Gly703Arg found buried within helices of the ectodomain catalytic lobe. We also revealed one new KEL*02M allele with p.Gly263Glu in contact with solvent (water) located within the second lobe of the ectodomain. One sample with c.575G>C transversion (p.Arg192Pro) on a KEL*02 background showed a weakened reactivity for KEL1. According to our 3D modeling, these amino acid substitutions may have a profound impact on the protein structure.CONCLUSION: This study is especially interesting with regard to the description of four new KEL*01M alleles. Indeed, to date only two KEL*01M alleles have been described and our data suggest a nonnegligible incidence of KEL1 variants. Serologic KEL2‐negative results as well as any ambiguity implying either KEL1 or KEL2 in donors should always be confirmed by means of genotyping analysis and discrepancies between these methods require sequencing of KEL gene.
- 20 March 2016
- Published by Wiley in Transfusion
- Vol. 56 (5) , 1223-1229
New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes
BACKGROUND: The KELL antigens are carried by the well‐folded and highly polymorphic glycoprotein KELL, belonging to the M13 family of metalloproteases. Anti‐KEL, particularly anti‐KEL1, are clinically significant. We retrospectively investigated genomic DNA from samples with uncertain KEL1 or KEL2 phenotype and identified six novel Kmod alleles. We then considered a model of the protein three‐dimensional (3D) structure to assess the impacts of the amino acid changes.STUDY DESIGN AND METHODS: The 19 exons of the KEL gene were polymerase chain reaction amplified and sequenced. Modeling was performed using the experimental 3D structure of human endothelin‐converting enzyme‐1 in the presence of the metabolite phosphoramidon.RESULTS: We identified four novel KEL*01M alleles with amino acid substitutions p.Arg447Trp, p.Gly641Arg, p.Ala645Val, and p.Gly703Arg found buried within helices of the ectodomain catalytic lobe. We also revealed one new KEL*02M allele with p.Gly263Glu in contact with solvent (water) located within the second lobe of the ectodomain. One sample with c.575G>C transversion (p.Arg192Pro) on a KEL*02 background showed a weakened reactivity for KEL1. According to our 3D modeling, these amino acid substitutions may have a profound impact on the protein structure.CONCLUSION: This study is especially interesting with regard to the description of four new KEL*01M alleles. Indeed, to date only two KEL*01M alleles have been described and our data suggest a nonnegligible incidence of KEL1 variants. Serologic KEL2‐negative results as well as any ambiguity implying either KEL1 or KEL2 in donors should always be confirmed by means of genotyping analysis and discrepancies between these methods require sequencing of KEL gene.
- 10 April 2015
- Published by Wiley in Transfusion
- Vol. 55 (6pt2) , 1423-1431
RH diversity in Mali: characterization of a new haplotypeRHD*DIVa/RHCE*ceTI(D2)
BACKGROUND: Knowledge of RH variants in African populations is critical to improving transfusion safety in countries with populations of African ancestry and to providing valuable information and direction for future development of transfusion in Africa. The purpose of this report is to describe RH diversity in individuals from Mali.STUDY DESIGN AND METHODS: Blood samples collected from 147 individuals self‐identified as Dogon and Fulani were analyzed for Rh antigens and alleles.RESULTS: The most commonRHDallele variant wasRHD*DAU0. Five predicted partial‐D phenotypes were attributed toRHD*DAU3orRHD*DIVa. NeitherRHD*DARnorRHD*DIIIawas found. Investigation ofRHCErevealed three predicted partial‐e antigens encoded byRHCE*ce(254G)in trans toRHCE*cE. Regarding C antigen, 28 Fulani typed as C+ and 16 of 28 harbored at least oneRHCE*Ce‐D(4)‐ce, two being homozygous and predicted to show a rare RH:32,−46 phenotype. A newRHCE*ceTIwith replacement of Exon 2 byRHD(RHCE*ceTI(D2))was identified in Dogon and was identified by inheritance study to be in cis toRHD*DIVa. These samples typed C– with anti‐C polyclonal antibody and monoclonal antibodies (MoAbs) MS24, P3X2551368+MS24, and MS273, but positive with anti‐RhCe MoAb‐BS58. The same pattern was observed in sample withRHD*DIVa/RHCE*ceTI.CONCLUSION: Our survey indicated an uneven distribution ofRHvariant alleles between Dogon and Fulani, suggesting that study in well‐documented cohorts is warranted. A high incidence of predicted partial‐C phenotype encoded byRHCE*Ce‐D(4)‐cewas found in Fulani. Further study will also be needed to clarify the clinical significance of the newDIVa/ceTI(D2)haplotype encoding partial D and variant ce antigens.
- 10 April 2015
- Published by Wiley in Transfusion
- Vol. 55 (6pt2) , 1423-1431
RH diversity in Mali: characterization of a new haplotypeRHD*DIVa/RHCE*ceTI(D2)
BACKGROUND: Knowledge of RH variants in African populations is critical to improving transfusion safety in countries with populations of African ancestry and to providing valuable information and direction for future development of transfusion in Africa. The purpose of this report is to describe RH diversity in individuals from Mali.STUDY DESIGN AND METHODS: Blood samples collected from 147 individuals self‐identified as Dogon and Fulani were analyzed for Rh antigens and alleles.RESULTS: The most commonRHDallele variant wasRHD*DAU0. Five predicted partial‐D phenotypes were attributed toRHD*DAU3orRHD*DIVa. NeitherRHD*DARnorRHD*DIIIawas found. Investigation ofRHCErevealed three predicted partial‐e antigens encoded byRHCE*ce(254G)in trans toRHCE*cE. Regarding C antigen, 28 Fulani typed as C+ and 16 of 28 harbored at least oneRHCE*Ce‐D(4)‐ce, two being homozygous and predicted to show a rare RH:32,−46 phenotype. A newRHCE*ceTIwith replacement of Exon 2 byRHD(RHCE*ceTI(D2))was identified in Dogon and was identified by inheritance study to be in cis toRHD*DIVa. These samples typed C– with anti‐C polyclonal antibody and monoclonal antibodies (MoAbs) MS24, P3X2551368+MS24, and MS273, but positive with anti‐RhCe MoAb‐BS58. The same pattern was observed in sample withRHD*DIVa/RHCE*ceTI.CONCLUSION: Our survey indicated an uneven distribution ofRHvariant alleles between Dogon and Fulani, suggesting that study in well‐documented cohorts is warranted. A high incidence of predicted partial‐C phenotype encoded byRHCE*Ce‐D(4)‐cewas found in Fulani. Further study will also be needed to clarify the clinical significance of the newDIVa/ceTI(D2)haplotype encoding partial D and variant ce antigens.
- 1 January 2015
- Vol. 13 (1) , 59-65
Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests
International audienceBACKGROUND: The choice of a molecular test for first intention determination of paternal RHD zygosity, before entering into invasive diagnostics, is important for the management of pregnancies at risk of haemolytic disease of the foetus and newborn related to anti-RhD. MATERIALS AND METHODS: RHD zygosity was evaluated in 370 RH:1 Tunisian donors by polymerase chain reaction - sequence-specific polymorphism (PCR-SSP) analysis and polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) amplification of hybrid Rhesus box and by real time quantitative polymerase chain reaction (RQ-PCR) specific for RHD exon 5. To evaluate the accuracy of molecular tests in the cases of discordant results, the ten exons of RHD and Rhesus boxes were amplified by PCR and sequenced. RESULTS: Molecular investigations revealed that our 370 donors comprise 193 dizygous and 145 hemizygous individuals and 32 subjects whose zygosity remains unknown. Positive predictive values were higher than 99% for all the methods, reaching 100% for RQ-PCR. Negative predictive values were 83.24%, 87.27% and 98% for PCR-SSP, PCR-RFLP and RQ-PCR respectively. This study also revealed 19 novel Rhesus box polymorphisms and three novel RHD alleles: RHD(Trp185Stop), RHD(Ala176Thr) and RHD(Ile342Ile). DISCUSSION: RQ-PCR is the most convenient method for first intention determination of paternal RHD zygosity in Tunisians. However, taking into account positive and negative predictive values, PCR-RFLP could be an alternative despite the heterogeneity of Rhesus boxes and the complexity of RHD
- 1 January 2015
- Vol. 13 (1) , 59-65
Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests
International audienceBACKGROUND: The choice of a molecular test for first intention determination of paternal RHD zygosity, before entering into invasive diagnostics, is important for the management of pregnancies at risk of haemolytic disease of the foetus and newborn related to anti-RhD. MATERIALS AND METHODS: RHD zygosity was evaluated in 370 RH:1 Tunisian donors by polymerase chain reaction - sequence-specific polymorphism (PCR-SSP) analysis and polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) amplification of hybrid Rhesus box and by real time quantitative polymerase chain reaction (RQ-PCR) specific for RHD exon 5. To evaluate the accuracy of molecular tests in the cases of discordant results, the ten exons of RHD and Rhesus boxes were amplified by PCR and sequenced. RESULTS: Molecular investigations revealed that our 370 donors comprise 193 dizygous and 145 hemizygous individuals and 32 subjects whose zygosity remains unknown. Positive predictive values were higher than 99% for all the methods, reaching 100% for RQ-PCR. Negative predictive values were 83.24%, 87.27% and 98% for PCR-SSP, PCR-RFLP and RQ-PCR respectively. This study also revealed 19 novel Rhesus box polymorphisms and three novel RHD alleles: RHD(Trp185Stop), RHD(Ala176Thr) and RHD(Ile342Ile). DISCUSSION: RQ-PCR is the most convenient method for first intention determination of paternal RHD zygosity in Tunisians. However, taking into account positive and negative predictive values, PCR-RFLP could be an alternative despite the heterogeneity of Rhesus boxes and the complexity of RHD
- 21 November 2014
- Published by Wiley in Transfusion
- Vol. 55 (6pt2) , 1407-1410
Short duplication within theRHCEgene associated with an in cis deletedRHDcausing aRhnullamorph phenotype in an immunized pregnant woman with anti‐Rh29
The rare amorph Rhnull phenotype is caused by silent alleles at the RH locus and usually arises in consanguineous families. To date, only five molecular backgrounds have been identified in five unrelated families. Subjects with Rhnull red blood cells (RBCs) readily produce alloantibodies to high-prevalence Rh antigens. RBCs from a pregnant woman (G5P3) from Libya, with a positive indirect antiglobulin test were phenotyped by hemagglutination. RHD and RHCE genes were analyzed at the genomic level and mutation inheritance pattern was assessed in the patient's family. Hemagglutination testing showed a D-C-E-c-e- phenotype in the proposita associated with the presence of a high titer anti-Rh29 (4096). Molecular analysis revealed a deletion of RHD and presence of a novel RHCE allele with a 7-bp duplication in Exon 7. This duplication is predicted to introduce a frameshift after His350, a new C-terminal sequence, and a premature stop codon resulting in shortened predicted protein with only 402 amino acids. The mutated allele was found at homozygous state in the proposita and heterozygous state in her parents and one brother. This report describes a novel RHCE mutation causing the loss of RhCE antigen expression in association with RHD deletion, leading to an amorph Rhnull phenotype.
- 21 November 2014
- Published by Wiley in Transfusion
- Vol. 55 (6pt2) , 1407-1410
Short duplication within theRHCEgene associated with an in cis deletedRHDcausing aRhnullamorph phenotype in an immunized pregnant woman with anti‐Rh29
The rare amorph Rhnull phenotype is caused by silent alleles at the RH locus and usually arises in consanguineous families. To date, only five molecular backgrounds have been identified in five unrelated families. Subjects with Rhnull red blood cells (RBCs) readily produce alloantibodies to high-prevalence Rh antigens. RBCs from a pregnant woman (G5P3) from Libya, with a positive indirect antiglobulin test were phenotyped by hemagglutination. RHD and RHCE genes were analyzed at the genomic level and mutation inheritance pattern was assessed in the patient's family. Hemagglutination testing showed a D-C-E-c-e- phenotype in the proposita associated with the presence of a high titer anti-Rh29 (4096). Molecular analysis revealed a deletion of RHD and presence of a novel RHCE allele with a 7-bp duplication in Exon 7. This duplication is predicted to introduce a frameshift after His350, a new C-terminal sequence, and a premature stop codon resulting in shortened predicted protein with only 402 amino acids. The mutated allele was found at homozygous state in the proposita and heterozygous state in her parents and one brother. This report describes a novel RHCE mutation causing the loss of RhCE antigen expression in association with RHD deletion, leading to an amorph Rhnull phenotype.
- 29 August 2013
- Published by Wiley in Transfusion
- Vol. 53 (11pt2) , 3009-3017
A comprehensive survey of both RHD and RHCE allele frequencies in sub‐Saharan Africa
Background: The RH system is one of the most polymorphic blood group systems with numerous allele variants affecting Rh polypeptides expression. This complexity is at the origin of difficulties for transfusion of African patients especially sickle cell disease patients requiring chronic transfusion therapy with high risk of immunization. As a complete survey of RH variants is lacking in African populations, we performed red blood cell genotyping to determine the type and frequency of RHD and RHCE alleles in sub‐Saharan African populations.Study Design and Methods: A total of 347 blood samples were collected from individuals of six nonpygmoid and three pygmoid populations. RH typing was performed using two single‐tube multiplex polymerase chain reaction amplifications (BioArray Solutions, Immucor).Results: All six sub‐Saharan nonpygmoid populations exhibited constant variety in both type and frequency of aberrant RHD and RHCE alleles. Predicted partial RH1 (1.8%) and RH5 (0.9%) phenotypes were less than expected. Conversely, predicted partial phenotype RH2 (5.5%) was frequent. Data confirmed the high frequency of samples positive for the non–clinically significant RH10/RH20 antigens (39.5%) and revealed a high frequency of RH54 (DAK, 8.1%). The pygmoid groups showed higher percentages of predicted partial RH antigens and greater heterogeneity reflecting wide genetic differentiation.Conclusion: Our data show that frequencies of aberrant RHD and RHCE alleles were similar, irrespective of location and ethnicity. In view of the predicted frequencies and relative clinical significance of both private antigens and high‐prevalence antigens absent, the most relevant assays for individuals of African descent in a transfusion setting are for 1) partial RH2 in the patient and 2) RH54 (DAK) in the donor.
- 29 August 2013
- Published by Wiley in Transfusion
- Vol. 53 (11pt2) , 3009-3017
A comprehensive survey of both RHD and RHCE allele frequencies in sub‐Saharan Africa
Background: The RH system is one of the most polymorphic blood group systems with numerous allele variants affecting Rh polypeptides expression. This complexity is at the origin of difficulties for transfusion of African patients especially sickle cell disease patients requiring chronic transfusion therapy with high risk of immunization. As a complete survey of RH variants is lacking in African populations, we performed red blood cell genotyping to determine the type and frequency of RHD and RHCE alleles in sub‐Saharan African populations.Study Design and Methods: A total of 347 blood samples were collected from individuals of six nonpygmoid and three pygmoid populations. RH typing was performed using two single‐tube multiplex polymerase chain reaction amplifications (BioArray Solutions, Immucor).Results: All six sub‐Saharan nonpygmoid populations exhibited constant variety in both type and frequency of aberrant RHD and RHCE alleles. Predicted partial RH1 (1.8%) and RH5 (0.9%) phenotypes were less than expected. Conversely, predicted partial phenotype RH2 (5.5%) was frequent. Data confirmed the high frequency of samples positive for the non–clinically significant RH10/RH20 antigens (39.5%) and revealed a high frequency of RH54 (DAK, 8.1%). The pygmoid groups showed higher percentages of predicted partial RH antigens and greater heterogeneity reflecting wide genetic differentiation.Conclusion: Our data show that frequencies of aberrant RHD and RHCE alleles were similar, irrespective of location and ethnicity. In view of the predicted frequencies and relative clinical significance of both private antigens and high‐prevalence antigens absent, the most relevant assays for individuals of African descent in a transfusion setting are for 1) partial RH2 in the patient and 2) RH54 (DAK) in the donor.